Al-Razi Medical Co. (9572.SR)

SAR 55.9

(2.57%)

EBITDA Summary of Al-Razi Medical Co.

  • Al-Razi Medical Co.'s latest annual EBITDA in 2023 was 5.64 Million SAR , down -1.22% from previous year.
  • Al-Razi Medical Co.'s latest quarterly EBITDA in 2024 Q2 was 512.13 Thousand SAR , down 0.0% from previous quarter.
  • Al-Razi Medical Co. reported an annual EBITDA of 5.72 Million SAR in 2022, up 20.03% from previous year.
  • Al-Razi Medical Co. reported an annual EBITDA of 5.12 Million SAR in 2021, down 0.0% from previous year.
  • Al-Razi Medical Co. reported a quarterly EBITDA of 512.13 Thousand SAR for 2024 Q1, down -8.33% from previous quarter.
  • Al-Razi Medical Co. reported a quarterly EBITDA of 558.69 Thousand SAR for 2023 Q3, down -33.57% from previous quarter.

Annual EBITDA Chart of Al-Razi Medical Co. (2023 - 2021)

Historical Annual EBITDA of Al-Razi Medical Co. (2023 - 2021)

Year EBITDA EBITDA Growth
2023 5.64 Million SAR -1.22%
2022 5.72 Million SAR 20.03%
2021 5.12 Million SAR 0.0%

Peer EBITDA Comparison of Al-Razi Medical Co.

Name EBITDA EBITDA Difference
Middle East Pharmaceutical Industries Co. 85.13 Million SAR 93.364%
Al-Dawaa Medical Services Company 830.43 Million SAR 99.32%
Nahdi Medical Company 1.64 Billion SAR 99.656%
Almujtama Alraida Medical Co. 19.53 Million SAR 71.075%